Zdrowie i gospodarka · 06/02/2015
FDA Reopens Docket for Generic Drug User Fee Amendments of 2012 Comments
The FDA is seeking public comments on the implementation of the Generic Drug User Fee Amendments of 2012 and the accompanying commitment letter, following a 2014 public hearing on policy development.